Off Patent
September 2027

Emend

aprepitant

Merck Sharp and Dohme LLC

Capsule (oral) · NDA 021549

Last listed protection ends
September 26, 2027

The FDA lists 1 patent for Emend, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Patent 8,258,132
    Claims the drug product and a use (U-1743, U-901)